Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial

Figure 3

Median plasmatic paclitaxel concentrations for patients treated with TAX alone (VPA 0) or with VPA + TAX (VPA 1000). Boxes = 25th and 75th percentiles; bars = min and max values.